INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $528,653 | -81.7% | 15,152 | -70.6% | 0.00% | -66.7% |
| Q3 2022 | $2,886,000 | -86.9% | 51,571 | -87.9% | 0.00% | -88.5% |
| Q2 2022 | $22,068,000 | +39.0% | 426,350 | +95.2% | 0.03% | +73.3% |
| Q1 2022 | $15,872,000 | +5003.5% | 218,409 | +8191.9% | 0.02% | – |
| Q4 2021 | $311,000 | -90.7% | 2,634 | -89.5% | 0.00% | -100.0% |
| Q3 2021 | $3,358,000 | -84.0% | 25,032 | -80.7% | 0.00% | -83.3% |
| Q2 2021 | $21,047,000 | -35.0% | 129,992 | -67.8% | 0.02% | -41.9% |
| Q1 2021 | $32,400,000 | +64.8% | 403,720 | +11.7% | 0.03% | +72.2% |
| Q4 2020 | $19,659,000 | +475.0% | 361,371 | +110.1% | 0.02% | +500.0% |
| Q3 2020 | $3,419,000 | -16.4% | 171,969 | -11.6% | 0.00% | -40.0% |
| Q2 2020 | $4,088,000 | +2109.7% | 194,461 | +1440.3% | 0.01% | – |
| Q4 2019 | $185,000 | – | 12,625 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |